Home / CRISPR THERAPEUTICS AG (CRSP)

Updated: 2026-03-17 00:37 UTC · Last close: 48.42 (-0.68%)

CRISPR THERAPEUTICS AG (CRSP) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.

CRISPR THERAPEUTICS AG (CRSP) closed at 48.42 (-0.68%). Price remains below both the 50-day and 200-day moving averages, which keeps the broader technical backdrop under pressure until stronger recovery signals appear. 20-day momentum is notably weak at -8.76%, with price remains inside its roughly 52-week range (31.27–76.78), while ATR14 volatility is elevated at roughly 7.87% of price. RSI(14) is 38.9, leaving momentum in a fairly neutral range. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram is negative and weakening further, which reflects continued downside pressure. From a pattern perspective, the main active signal is Double top. The nearest decision zone is framed by support at 45.53 and resistance at 54.28. A move through resistance would improve the short-term technical tone, while a loss of support would weaken the current structure. Latest fundamentals snapshot: Revenue: 157,000 · Net income: -581.60M · EPS (basic): -6.47. The interactive view adds overlays, pattern context and broader chart structure for deeper review.

OPEN FULL INTERACTIVE ANALYSIS

Note: This is an algorithmic technical snapshot (not financial advice).

CRSP Chart